Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02859038 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Study of Upfront Surgery Versus Neoadjuvant Chemotherapy in Patients With Advanced Ovarian Cancer (SUNNY)

StatusActive, Not Recruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion dates: Jun 2023 to Jun 2027
    • Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 488 to confirmed 489
    • Site details revised at 8 of 8 sites
    v5
  2. Enrollment target: 456 to 488
    • Primary and study completion dates: Dec 2022 to Jun 2023
    • Secondary endpoints: 5 to 9
    • Study description revised
    v4
  3. Start date: Dec 2015 to Aug 2016
    • Study sites: 7 to 8
    • Secondary endpoints: 3 to 5
    v3
  4. Study sites: 3 to 7v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to answer the fundamental question, should the physicians choose Surgery or Chemotherapy (SOC-2) in advanced ovarian cancer?
Trial Details
NCT Number NCT02859038
Lead Sponsor Shanghai Gynecologic Oncology Group
Conditions
(from sponsor)		 Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma
Related terms Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms
Enrollment 489 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov